Answers are grounded in this paper and cite their sources.
Identifies oral glucocorticoid use as a risk factor for heart failure, highlighting the need for randomized trials to assess disease activity.
Oral glucocorticoid use was identified as a risk factor for heart failure. However, the evidence remains observational and only a randomised controlled trial of glucocorticoid treatment versus other disease modifying agents is likely to distinguish the importance of the underlying disease activity from its treatment in predicting cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Souverein et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: